BC Biomedical’s ESU-2400H Electrosurgical Unit Analyzer’s DFA2 Technology is now patented under U.S. Patent No. 9,883,903.
The newly patented technology allows the ESU-2400H to aggressively digitize the complex RF waveforms produced by electrosurgical generators. Each data point is analyzed to provide highly accurate measurement results, according to a press release from BC Biomedical announcing the patent.
“The ESU-2400H is able to digitize complex RF waveforms due to its low impedance internal load bank, which has a wide range of 0 to 6400 ohms, in as little as one-ohm increments. It is a microprocessor-based analyzer that utilizes a combination of unique hardware and software to provide accurate and reliable test results, even from ‘noisy’ electrosurgical generator waveforms such as ‘Spray,’ ” according to the release.
“The ESU-2400H, unlike most conventional ESU analyzers, has internal high voltage setup relays to control the measurement path. This allows the user to switch between power measurements, leakage measurements, REM/ARM/CQM testing, or even run an autosequence that could include any or all of these tests – without even moving wires around,” the release adds.
“The current transformer internal to the ESU-2400H senses the RF current flowing through the internal test load and produces a ratiometric voltage, which is digitized and analyzed by the microprocessor. Combining the standard and low ranges of the ESU-2400H with the use of the current transformer, the user has full control over the ability to get high-accuracy and high-resolution readings from all types of electrosurgical generators,” the release states.
For information about the ESU-2400H, contact BC Biomedical by phone at 800-242-8428 or via email at firstname.lastname@example.org. Those interested can view BC Biomedical’s complete line of products – including pricing, datasheets and manuals – online at www.BCGroupStore.com.
© 2018, TechNation Magazine. Site designed by MD Publishing, Inc.